12:00 AM
 | 
Aug 12, 2013
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Aerpio Therapeutics preclinical data

Researchers at Massachusetts General Hospital and colleagues reported data from mouse models of breast cancer showing that AKB-9778 delayed tumor growth, slowed metastatic progression and...

Read the full 105 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >